Хайлтын үр дүнгүүд - Giuseppe Procopio
- 60-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib -н G. Mickisch, M. Gore, Bernard Escudier, Giuseppe Procopio, Stefan Walzer, Mark Nuijten
Хэвлэсэн 2009Artigo -
2
-
3
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy -н Roberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, Matteo Santoni, Patrizia Trenta, Angelina De Benedetto, Silvia Mezi, Enrico Cortesi
Хэвлэсэн 2013Revisão -
4
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma -н Thomas Powles, Laurence Albigès, Axel Bex, Viktor Grünwald, Camillo Porta, Giuseppe Procopio, Manuela Schmidinger, Cristina Suárez, Guillermo de Velasco
Хэвлэсэн 2021Artigo -
5
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial -н Giuseppe Procopio, Elena Verzoni, Sergio Bracarda, Serafino Ricci, Cosimo Sacco, Laura Ridolfi, Camillo Porta, Rosalba Miceli, Nicoletta Zilembo, Emilio Bajetta
Хэвлэсэн 2011Artigo -
6
5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors -н Emilio Bajetta, Lorenza Rimassa, Carlo Carnaghi, Ettore Seregni, Leonardo Ferrari, Maria Di Bartolomeo, Enrico Regalia, Antonio Cassata, Giuseppe Procopio, Luigi Mariani
Хэвлэсэн 1998Artigo -
7
Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis -н Giuseppe Procopio, Joaquim Bellmunt, Janice P. Dutcher, Sergio Bracarda, Jennifer J. Knox, Andreas Brueckner, István Molnár, Bernard Escudier, Thomas E. Hutson
Хэвлэсэн 2013Artigo -
8
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer -н Alessandra Raimondi, Pierangela Sepe, Emma Zattarin, Alessia Mennitto, Marco Stellato, Mélanie Claps, Valentina Guadalupi, Elena Verzoni, Filippo de Braud, Giuseppe Procopio
Хэвлэсэн 2020Revisão -
9
Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women -н Emilio Bajetta, Giuseppe Procopio, Luigi Celio, Luca Gattinoni, S. Della Torre, Luigi Mariani, Laura Catena, Riccardo Ricotta, Raffaella Longarini, Nicoletta Zilembo, Roberto Buzzoni
Хэвлэсэн 2005Artigo -
10
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials -н Matteo Santoni, Alessandro Conti, Francesco Massari, Giorgio Arnaldi, Roberto Iacovelli, Mimma Rizzo, Ugo De Giorgi, Laura Trementino, Giuseppe Procopio, Giampaolo Tortora, Stefano Cascinu
Хэвлэсэн 2014Revisão -
11
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? -н Emilio Bajetta, Laura Catena, Giuseppe Procopio, E. Bichisao, L. Ferrari, S. Della Torre, Sara De Dosso, Silvia Iacobelli, Roberto Buzzoni, Luigi Mariani, J Rosai
Хэвлэсэн 2005Artigo -
12
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression -н Vera Cappelletti, Elena Verzoni, Raffaele Ratta, Marta Vismara, Marco Silvestri, Rosanna Montone, Patrizia Miodini, Carolina Reduzzi, Mélanie Claps, Pierangela Sepe, Maria Grazia Daidone, Giuseppe Procopio
Хэвлэсэн 2020Artigo -
13
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage? -н Alessia Mennitto, Veronica Huber, Raffaele Ratta, Pierangela Sepe, Filippo de Braud, Giuseppe Procopio, Valentina Guadalupi, Mélanie Claps, Marco Stellato, Elena Daveri, Licia Rivoltini, Elena Verzoni
Хэвлэсэн 2020Revisão -
14
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma -н Giuseppe Procopio, Pierangela Sepe, Mélanie Claps, Sebastiano Buti, Maurizio Colecchia, Patrizia Giannatempo, Valentina Guadalupi, Luigi Mariani, Luca Lalli, Giovanni Fucá, Filippo de Braud, Elena Verzoni
Хэвлэсэн 2022Artigo -
15
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives -н Alfredo Berruti, Sergio Bracarda, Orazio Caffo, Enrico Cortesi, Rolando Maria D’Angelillo, Marzia Del Re, Gaetano Facchini, Giovanni Pappagallo, Giuseppe Procopio, Roberto Sabbatini, Daniele Santini
Хэвлэсэн 2023Revisão -
16
Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours -н Emilio Bajetta, L. Ferrari, Giuseppe Procopio, Laura Catena, Erminia Ferrario, Antonia Martinetti, Maria Di Bartolomeo, Roberto Buzzoni, Luigi Celio, Milena Vitali, Elena Beretta, Ettore Seregni, Emilio Bombardieri
Хэвлэсэн 2002Artigo -
17
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings -н Jochaim Beck, Giuseppe Procopio, Emilio Bajetta, Ulrich Keilholz, Sylvie Négrier, Cezary Szczylik, Carsten Bokemeyer, Sergio Bracarda, D. J. Richel, Michael Staehler, U.P. Strauss, Sabine Mersmann, K. Burock, Bernard Escudier
Хэвлэсэн 2011Artigo -
18
Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima -н Hideyuki Akaza, Giuseppe Procopio, Choosak Pripatnanont, Gaetano Facchini, S. Fava, Duncan Wheatley, K.C. Leung, Mohammad Butt, A. Silva, Lucía Castillo, George Fountzilas, Simon Hitier, Evelyne Ecstein-Fraïsse, Samira Bensfia, Mustafa Özgüroğlu
Хэвлэсэн 2014Artigo -
19
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study) -н Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Sebastiano Buti, Giuseppe Procopio, Ugo De Giorgi, Sandro Pignata, Emanuele Naglieri, Marco Maruzzo, Giuseppe Luigi Banna, Pasquale Rescigno, Carlo Messina, Alvise Mattana, Umberto Basso, Davide Bimbatti
Хэвлэсэн 2024Artigo -
20
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for... -н Pier Vitale Nuzzo, Filippo Pederzoli, Calogero Saieva, Elisa Zanardi, Giuseppe Fotia, Andrea Malgeri, Sabrina Rossetti, Loana Valenca Bueno, Livia Andrade, Anna Patrikidou, Ricardo Pereira Mestre, Mikol Modesti, Sandro Pignata, Giuseppe Procopio, Giuseppe Fornarini, Ugo De Giorgi, Antonio Russo, Edoardo Francini
Хэвлэсэн 2023Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Oncology
Cancer
Renal cell carcinoma
Immunotherapy
Adverse effect
Surgery
Gastroenterology
Prostate cancer
Clinical trial
Urology
Confidence interval
Androgen receptor
Chemotherapy
Nivolumab
Pathology
Pembrolizumab
Sunitinib
Tolerability
Biochemistry
Clinical endpoint
Gene
Androgen deprivation therapy
Chemistry
Olaparib
Poly ADP ribose polymerase
Polymerase
Environmental health
Hepatocellular carcinoma